Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03139708 · ClinicalTrials.gov registry record · Phase 1
The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients
A Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT03139708 is a Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 5 participants.
The verdict
NCT03139708, a Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This an interventional study looking at two different sequences of pre-operative eye drops, to determine which order is more effective in reducing intraocular pressure with pupil dilation.
Interventions
- DRUG Phenylephrine
- DRUG Tropicamide
- DRUG Alphagan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03139708
The ClinicalTrials.gov registry entry for NCT03139708 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Phenylephrine is the first listed.
NCT03139708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03139708 about?
NCT03139708 is a clinical study titled "The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients". This an interventional study looking at two different sequences of pre-operative eye drops, to determine which order is more effective in reducing intraocular pressure with pupil dilation.
What is the current status of trial NCT03139708?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2016-09. Estimated completion is 2017-10.
What interventions are being tested in trial NCT03139708?
The interventions under investigation include: Phenylephrine (DRUG), Tropicamide (DRUG), Alphagan (DRUG).
Who is sponsoring clinical trial NCT03139708?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.